Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0001209191-24-002476

Options or other derivatives

  • Director acquired 6,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Woosley Raymond L. Director 2024-01-30 Grant or award · Stock Option (right to buy) +6,000 6,000 D
Loading xslF345X05/doc4.xml…